Physician
Hematology
Dr. Leslie R. Laufman, MD
|
|
Give Review
Leslie Laufman works in the field of Hematology. She went to University of Pittsburgh School of Medicine. Leslie R. Laufman, MD is also a published physician. She has 39 paper published. The most recent paper is: Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies. Dr. Leslie R. Laufman is registered with Medicare.
Publications
- Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with Cancer receiving chemotherapy.
- Phase I study of Doxil and vinorelbine in patients With advanced malignancies.
- Hematoporphyrin-derivative and photoradiation therapy of malignant tumors.
- Phase II trial of didemnin-B in advanced epithelial ovarian Cancer. A Southwest Oncology Group study.
- Didemnin B in metastatic malignant Melanoma: a phase II trial of the Southwest Oncology Group.
- Hispanic women's breast and cervical Cancer knowledge, attitudes, and screening behaviors.
- Clinical experience With leucovorin and 5-fluorouracil.
- Cholesterol screening using the school as a worksite.
- Evaluation of topotecan in resistant and relapsing multiple Myeloma: a Southwest Oncology Group study.
- Hepatic artery ligation and portal vein infusion for liver metastases from colon Cancer.
- Quality of life in patients with metastatic coloRectal cancer receiving chemotherapy: a randomized, double-blind trial comparing 5-FU versus 5-FU with leucovorin.
- Pediatric residents' performance of ankle and knee examinations after an educational intervention.
- Development and evaluation of a method for evaluating pediatric residents' knowledge and skill in performing physical examinations of the ankle and knee.
- Community outreach With weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent ...
- Case report of a lethal cardiac toxic effect following high-dose cyclophosphamide.
- Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung Cancer. A useful outcome predictor.
- Pregnancy-Associated factor VIII inhibitor: treatment with intravenous high-dose immunoglobulin.
- A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients With refractory myeloma. A Southwest Oncology Group study.
- Adjuvant therapy in large bowel adenoCarcinoma: long-term results of a Southwest Oncology Group Study.
- Chemotherapy of drug-resistant ovarian Cancer: a Southwest Oncology Group Study.
- Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung Carcinoma: a Phase II study of the Southwest Oncology Group.
- Leucovorin plus 5-fluorouracil: an effective treatment for metastatic colon Cancer.
- Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung Cancer: a phase II study of the Southwest ...
- Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast Cancer: findings from National Surgical Adjuvant Bre...
- Photodynamic therapy for Esophageal malignancy: a prospective twelve-year study.
- Docetaxel and gemcitabine combinations in chemotherapy-pretreated non small-cell lung Cancer.
- A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic coloRectal cancer.
- Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung Cancer: results of a multicenter phase II study.
- A phase II evaluation of high dose cisplatin and etoposide in patients with advanced esophageal adenoCarcinoma.
- Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast Cancer.
- Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast Cancer.
- Daily times four vinorelbine plus cisplatin in advanced non-small-cell lung Cancer: a phase II trial of a novel schedule.
- Second-line chemotherapy for non-small-cell lung Cancer with monthly docetaxel and weekly gemcitabine: a phase II trial.
- Monthly docetaxel and weekly gemcitabine in metastatic breast Cancer: a phase II trial.
- Phase I study of docetaxel dose escalation in combination With fixed weekly gemcitabine in patients With advanced malignancies.
- Multicenter phase II study of oral bexarotene for patients with metastatic breast Cancer.
- Overlooking patient outcomes in a meta-Analysis of trials of granulocyte colony-stimulating factor.
- Primary androgen deprivation therapy in men with prostate Cancer.
Schools
University of Pittsburgh School of Medicine
Montefiore Hospital
Ohio State University
Ohio Wesleyan University
Procedures Preformed
- Abdominal Paracentesis
- Therapeutic Phlebotomy
- Thoracentesis
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Blood Disorders
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Adult Hematology
- Breast Oncology
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Ohio State University Hospital -
University of Pittsburgh School of Medicine
Hospital
-
Ohio State University Wexner Medical Center -
OhioHealth Riverside Methodist Hospital
Drug Facts
| NPI NUMBER | 1336258516 | |
| NPPES Provider LastName | LAUFMAN | |
| NPPES Provider FirstName | LESLIE | |
| NPPES Provider ZIPCode | 432353228 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 344.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 16.0 | |
| Percent Opioid Claims | 4.65 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1336258516 |
| Last Name Of The Provider | LAUFMAN |
| First Name Of The Provider | LESLIE |
| View All |
Similar Doctors
|
Dr. Yvonne A. Efebera, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Craig C. Hofmeister, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Jane M. Leiby, MD |
|
|
Dr. Bhavana Bhatnagar, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ramiro Garzon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathon B. Cohen, MD |
|
|
Dr. Peter G. Shields, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Miguel A. Villalona-Calero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara L. Weber, MD |
|
Dr. Sam L. Penza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine R. Exten, MD |
|
|
Dr. Nick P. Trifelos, MD |